2017 Agenda


  • Clinical Trials as a Care Option: Bring Clinical Research Closer to Patients & Patients Closer to Clinical Trials


  • Clinical Research as a Care Option: Making this a Reality (CRAACO)

    Arguably the greatest change we can collaborate on in bringing patients closer to clinical research is to make clinical trials a care option. Higher rates of clinical trial participation inside of a health system produces better patient outcomes, lower cost of care and happier patients. Health systems and patients get access to the latest research and pharma gets access to more patients. The entire afternoon of CTC is dedicated to working through the process in how to make this a reality and how to scale up?

  • 1:30 pm

  • Co-Chairs' Welcome

    Jeffry_James-bw-new
    Jeff James
    CEO, Wilmington Health

    Katherine_Vandebelt_bw
    Katherine Vandebelt

    Global Head, Clinical Innovation, Eli Lilly & Company

  • 1:40 pm

  • Keynote Speaker Panel: Bridging Healthcare to Life Science

    Moderator:
    Jennifer Byrne B&W
    Jennifer Byrne

    Founder, Greater Gift Initiative

    John McConnell B&W
    John McConnell, MD

    CEO, Wake Forest University Medical Center

    Tom Pike
    Tom Pike

    Life Science Advisor, Former CEO, Quintiles

  • 2:20 pm

  • Accountable Care Organization (ACO): Clinical Research as a Counter Measure

    Healthcare is moving quickly towards a value based system where quality, cost and experience are transparent to the patient. This value proposition will cause changes in physician and patient behavior. The connection between clinical research and population health and value is starting to become clear. This discussion will focus on how organizations are using clinical research in conjunction with their Accountable Care Organization to drive towards value.

    Moderated by:
    Jeffry_James-bw-new
    Jeff James

    CEO, Wilmington Health

    Panelists:
    Kenneth_Bilgebw2
    Kenneth Bilger

    CEO, Christie Clinic

    Robert Matthews B&W
    Robert Matthews
    President and CEO, Medisync

  • 3:05 pm

  • Refreshment & Networking Break

  • 3:35 pm

  • Value-Based Health Care Delivery: Improve Value for Patients

    Value-based health care delivery claims to improve value for patients by improving processes and reducing costs without sacrificing outcomes. With this central goal, healthcare enterprises need to measure and be accountable for patient outcomes with a given medical condition in the care cycle. The International Consortium for Health Outcomes Measurement (ICHOM), convenes groups of global experts on specific conditions together with patients to define minimum standard outcome sets and risk factors for each medical condition. These outcome standards are putting providers, payers, patients, and information technology vendors on a common path for tracking what needs to be tracked and making implementation of outcomes measurement easier and more efficient. This discussion will explore opportunities to interface research driven value based care delivery in the patient’s care cycle.

    Moderated by:
    Meredith_Alger-bw
    Meredith Alger

    Healthcare Researcher, Program Manager, Harvard Business School

    Panelists:
    Christina Akerman-bw
    Christina Akerman, MD

    President, International Consortium of Health Outcome Measurements (ICHOM)

    Toyin Okanlawon B&W
    Toyin Okanlawon, MD

    Senior Researcher, Harvard Business School, Institute for Strategy & Competitiveness

  • 4:20 pm

  • Data Science to Drive Value for Research and Care Delivery

    Transforming the life sciences through data science is a work in progress to enable and accelerate evidence-based, data-driven decision-making. This discussion will highlight opportunities for life science organizations to create value from data science in ways that are technical and organizational in which aligns incentives and make it easier for physicians to conduct clinical research, improve data quality, and preserve patient safety. The power of integrated, data-science led analytics can boost the research and care interfaces, improve health outcomes and transform the care experience from the patient’s viewpoint.

    Moderated by:
    Craig Lipset B&W New
    Craig Lipset

    Head of Clinical Innovation, R&D, Pfizer

    Panelists:
    William_Crown-bw3
    William Crown, PhD

    Chief Science Officer, Optum Labs

    Ken Mandi-bwnew
    Kenneth Mandl, MD

    Director, Computational Health Informatics Program / Professor, Boston Children’s Hospital / Harvard Medical School

    Kyu Rhee-new-bw
    Kyu Rhee, MD

    Chief Health Officer, IBM

  • 5:05 pm

  • Co-Chairs' Closing Remarks

    Jeffry_James-bw-new
    Jeff James

    CEO, Wilmington Health

    Katherine_Vandebelt_bw
    Katherine Vandebelt

    Global Head, Clinical Innovation, Eli Lilly & Company